歡迎來到上海通蔚!

021-54845833/15800441009

品質(zhì)保證 · 通蔚試劑

當前位置: 首頁 > 科研產(chǎn)品 > 科研抗體 > 一抗 > 兔抗MYH11多克隆抗體
  • 兔抗MYH11多克隆抗體

    規(guī)格:
    數(shù)量:

    購買數(shù)量

    價格:
    • 品牌 : 通蔚生物
    • 目錄號 : TW20141
    • 應(yīng)用 : 僅供科研使用
    • 保存條件 : 低溫保存
    • 貨期 : 現(xiàn)貨
    • 商品庫存:80
  • 商品詳情
  • 參考文獻
  • 說明書下載
  • 商品評論0
  • 相關(guān)產(chǎn)品

中文名稱:  兔抗MYH11多克隆抗體


英文名稱:  Anti-MYH11 rabbit polyclonal antibody


別       名:  AAT4, FAA4, SMHC, SMMHC


相關(guān)類別:  一抗


儲      存:  冷凍(-20℃)


宿      主:  Rabbit


抗      原:  MYH11


反應(yīng)種屬:  Human, Mouse, Rat


標  記 物:  Unconjugate


克隆類型:  rabbit polyclonal


技術(shù)規(guī)格

Background:

The protein encoded by this gene is a smooth muscle myosin belonging to the myosin heavy chain family. The gene product is a subunit of a hexameric protein that consists of two heavy chain subunits and two pairs of non-identical light chain subunits. It functions as a major contractile protein, converting chemical energy into mechanical energy through the hydrolysis of ATP. The gene encoding a human ortholog of rat NUDE1 is transcribed from the reverse strand of this gene, and its 3' end overlaps with that of the latter. The pericentric inversion of chromosome 16 [inv(16)(p13q22)] produces a chimeric transcript that encodes a protein consisting of the first 165 residues from the N terminus of core-binding factor beta in a fusion with the C-terminal portion of the smooth muscle myosin heavy chain. This chromosomal rearrangement is associated with acute myeloid leukemia of the M4Eo subtype. Alternative splicing generates isoforms that are differentially expressed, with ratios changing during muscle cell maturation. Alternatively spliced transcript variants encoding different isoforms have been identified.

Applications:

ELISA, IHC

Name of antibody:

MYH11

Immunogen:

Synthetic peptide of human MYH11

Full name:

Myosin, heavy chain 11, smooth muscle

Synonyms:

AAT4, FAA4, SMHC, SMMHC

SwissProt:

P35749

ELISA Recommended dilution:

2000-10000

IHC positive control:

Human brain and Human cervical cancer

IHC Recommend dilution:

50-200